,mean_rank,weight
cervix,4.0,3.0
lung carcinoma,21.0,1.0
endometrioid stromal sarcoma,28.0,3.0
adrenal gland,29.0,3.0
small cell lung carcinoma,38.5,88.0
pancreatic somatostatinoma,44.0,3.0
embryonal carcinoma,54.0,1.0
adrenal gland neuroblastoma,55.0,5.0
thyroid gland squamous cell carcinoma,56.0,3.0
medulloblastoma,72.0,8.0
embryonal rhabdomyosarcoma,74.0,6.0
lung carcinoid tumor,74.5,6.0
neuroblastoma,77.0,52.0
vertebra,77.5,2.0
brain,83.5,16.0
gastric adenosquamous carcinoma,83.5,2.0
testicular embryonal carcinoma,85.0,1.0
right pararenal lymph node,91.0,2.0
not specified,94.0,3.0
hereditary thyroid gland medullary carcinoma,95.0,1.0
multiple endocrine neoplasia type 2,95.0,1.0
cervical small cell carcinoma,96.0,1.0
gastric small cell neuroendocrine carcinoma,103.5,4.0
right thigh skin,105.0,2.0
salivary gland squamous cell carcinoma,105.0,3.0
supraclavicular lymph node,106.0,3.0
skin nodule,109.0,1.0
right anterior leg,111.0,3.0
cervical squamous cell carcinoma,134.0,1.0
neurofibromatosis type 1,139.0,1.0
abdomen,140.0,2.0
ewing sarcoma,142.0,31.0
mediastinal lymph node,143.0,1.0
ovarian carcinoma,144.0,6.0
osteosarcoma,155.0,23.0
lung mucoepidermoid carcinoma,157.0,3.0
alveolar rhabdomyosarcoma,162.0,9.0
prostate carcinoma,167.0,11.0
high grade ovarian serous adenocarcinoma,169.5,40.0
papillary renal cell carcinoma,173.0,5.0
primitive neuroectodermal tumor,174.0,2.0
pharyngeal squamous cell carcinoma,181.0,3.0
rhabdomyosarcoma,183.0,4.0
ovarian granulosa cell tumor,185.0,2.0
myeloid leukemia associated with down syndrome,185.0,1.0
astrocytoma,186.0,19.0
ovarian serous adenocarcinoma,187.0,7.0
pleural epithelioid mesothelioma,190.0,18.0
endometrial adenosquamous carcinoma,190.5,6.0
supra-orbital region,201.0,1.0
ovarian endometrioid adenocarcinoma,204.0,11.0
thyroid gland follicular carcinoma,204.5,10.0
oligodendroglioma,211.0,5.0
undifferentiated gallbladder carcinoma,215.0,1.0
pleural sarcomatoid mesothelioma,225.5,8.0
inguinal lymph node,228.0,3.0
large cell lung carcinoma,234.5,32.0
glioblastoma,234.5,84.0
squamous papilloma,240.0,1.0
spleen,240.0,3.0
chondrosarcoma,240.0,10.0
vaginal melanoma,245.0,1.0
bone marrow,250.0,65.0
groin lymph node,254.0,5.0
peritoneal ascites,257.0,2.0
skin squamous cell carcinoma,258.0,1.0
ovarian leiomyosarcoma,270.0,3.0
thoracic lymph duct,271.0,1.0
subserosa of fallopian tube,272.0,1.0
endometrial carcinoma,273.5,8.0
small intestine,275.0,1.0
liposarcoma,280.0,1.0
biphasic synovial sarcoma,286.0,1.0
squamous cell lung carcinoma,288.5,48.0
breast carcinoma,289.0,27.0
bone,290.0,1.0
esophageal squamous cell carcinoma,291.0,59.0
adenosquamous lung carcinoma,293.0,9.0
minimally invasive lung adenocarcinoma,293.5,16.0
melanoma,296.5,94.0
ovarian serous cystadenocarcinoma,298.0,4.0
abdominal wall,298.0,2.0
lung giant cell carcinoma,298.5,4.0
benign prostatic hyperplasia,302.0,1.0
uterine carcinosarcoma,305.0,2.0
thyroid gland undifferentiated (anaplastic) carcinoma,309.0,13.0
laryngeal squamous cell carcinoma,310.5,12.0
ovarian mixed germ cell tumor,311.0,1.0
renal cell carcinoma,311.0,37.0
hypopharyngeal squamous cell carcinoma,313.0,5.0
lymph node,318.0,105.0
ovarian mucinous adenocarcinoma,324.0,4.0
pancreatic carcinoma,327.0,12.0
omentum,334.0,7.0
"squamous cell breast carcinoma, acantholytic variant",335.0,3.0
pleural effusion,338.5,224.0
left leg muscle,339.0,3.0
bronchogenic carcinoma,340.0,2.0
subcutaneous,340.0,7.0
cutaneous melanoma,340.5,26.0
bladder carcinoma,342.0,51.0
hepatocellular carcinoma,343.0,51.0
cervical lymph node,344.0,5.0
uterine corpus sarcoma,351.0,3.0
ascites,353.0,103.0
celiac axis lymph node,357.5,2.0
erythroleukemia,358.0,3.0
ovarian cystadenocarcinoma,358.5,6.0
brca2 syndrome,363.0,1.0
invasive lobular breast carcinoma,366.0,1.0
tongue squamous cell carcinoma,376.5,34.0
clear cell renal cell carcinoma,379.5,18.0
lung adenocarcinoma,382.0,145.0
mucinous gastric adenocarcinoma,383.0,3.0
mycosis fungoides and sezary syndrome,384.0,2.0
intrahepatic cholangiocarcinoma,385.5,6.0
ovarian adenocarcinoma,387.0,5.0
pelvic wall,387.0,3.0
lung,388.0,7.0
rectosigmoid adenocarcinoma,388.0,3.0
pleural biphasic mesothelioma,392.0,7.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,397.0,3.0
gingival squamous cell carcinoma,398.0,2.0
myelodysplastic syndrome,398.0,1.0
pancreatic adenocarcinoma,400.0,39.0
adrenal cortex carcinoma,403.0,1.0
"chronic eosinophilic leukemia, not otherwise specified",405.0,1.0
bladder squamous cell carcinoma,406.0,3.0
axillary lymph node,406.0,6.0
skin,409.0,3.0
endometrial adenocarcinoma,412.5,34.0
natural killer cell lymphoblastic leukemia/lymphoma,413.0,1.0
plasma cell myeloma,413.5,30.0
fibrosarcoma,415.0,5.0
"invasive ductal carcinoma, not otherwise specified",417.0,30.0
ovarian clear cell adenocarcinoma,417.0,13.0
gastric carcinoma,421.5,12.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",423.5,2.0
marek disease,425.0,1.0
chronic lymphocytic leukemia,426.0,2.0
ovarian mucinous cystadenocarcinoma,427.5,2.0
burkitt lymphoma,429.5,8.0
pancreatic adenosquamous carcinoma,431.0,5.0
poorly differentiated thyroid gland carcinoma,432.0,3.0
malignant ovarian brenner tumor,434.0,1.0
n/a,436.0,34.0
breast adenocarcinoma,438.0,23.0
adult acute monocytic leukemia,438.0,5.0
amelanotic melanoma,438.0,16.0
uterine corpus leiomyosarcoma,439.0,3.0
brachialis muscle,440.0,3.0
ampulla of vater adenocarcinoma,440.5,2.0
askin tumor,442.0,2.0
intraperitoneal,443.0,1.0
duodenal adenocarcinoma,444.0,1.0
gastric adenocarcinoma,444.0,26.0
ductal breast carcinoma,447.5,32.0
acute myeloid leukemia,449.0,1.0
vulvar leiomyosarcoma,451.0,3.0
anaplastic astrocytoma,453.0,5.0
left supraclavicular lymph node,456.0,4.0
recurrent bladder carcinoma,458.0,3.0
non-small cell lung carcinoma,461.5,24.0
gliosarcoma,463.5,6.0
hilar cholangiocarcinoma,464.0,1.0
pelvis; innominate bone,464.5,2.0
hodgkin lymphoma,465.0,11.0
obturator lymph node,471.0,3.0
liver,471.0,32.0
"chronic myelogenous leukemia, bcr-abl1 positive",472.0,16.0
diffuse large b-cell lymphoma germinal center b-cell type,473.0,8.0
cecum adenocarcinoma,474.0,18.0
gastric tubular adenocarcinoma,475.0,11.0
oral dysplasia,482.0,1.0
rhabdoid tumor of the kidney,483.0,3.0
b acute lymphoblastic leukemia,490.0,5.0
pancreatic ductal adenocarcinoma,492.0,39.0
childhood acute myeloid leukemia,498.5,2.0
cystic fibrosis,502.5,2.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",504.0,2.0
undifferentiated pleomorphic sarcoma,504.5,4.0
lymphoma,507.0,1.0
human papillomavirus-related endocervical adenocarcinoma,509.0,4.0
right axillary lymph node,511.0,1.0
hepatoblastoma,511.0,4.0
pericardial effusion,512.5,8.0
cutaneous t-cell non-hodgkin lymphoma,516.5,2.0
pleural malignant mesothelioma,519.0,5.0
colon adenocarcinoma,519.0,61.0
anaplastic large cell lymphoma,524.0,8.0
down syndrome,532.0,2.0
mantle cell lymphoma,533.0,6.0
lymphoblastic lymphoma,533.0,1.0
b-cell prolymphocytic leukemia,537.0,2.0
oral cavity squamous cell carcinoma,543.5,6.0
peripheral blood,544.0,107.0
childhood t acute lymphoblastic leukemia,544.0,19.0
familial adenomatous polyposis,546.0,1.0
colon carcinoma,546.0,19.0
cholangiocarcinoma,546.5,2.0
epithelioid cell type gastrointestinal stromal tumor,547.0,3.0
b-cell non-hodgkin lymphoma,548.0,7.0
vulvar squamous cell carcinoma,559.0,3.0
peritoneum,574.0,1.0
peritoneal effusion,575.5,6.0
human papillomavirus-related cervical squamous cell carcinoma,577.5,8.0
epstein-barr virus-related burkitt lymphoma,582.0,10.0
cerebrospinal fluid,584.0,3.0
adult t acute lymphoblastic leukemia,587.0,5.0
head and neck squamous cell carcinoma,592.0,9.0
barrett adenocarcinoma,595.0,3.0
childhood t lymphoblastic lymphoma,601.0,2.0
signet ring cell gastric adenocarcinoma,605.0,9.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),609.5,4.0
rectal adenocarcinoma,611.0,11.0
cervical carcinoma,612.0,2.0
esophageal adenocarcinoma,613.0,9.0
subcutaneous; right buttock,614.0,3.0
mediastinal (thymic) large b-cell lymphoma,618.0,1.0
thigh skin,620.0,1.0
papillary lung adenocarcinoma,624.0,3.0
brca1 syndrome,628.0,1.0
diffuse large b-cell lymphoma,629.5,20.0
buttock,632.5,2.0
parotid gland mucoepidermoid carcinoma,636.0,1.0
gallbladder carcinoma,641.0,2.0
vulvar carcinoma,641.0,1.0
buccal mucosa squamous cell carcinoma,644.5,2.0
hairy cell leukemia,646.0,3.0
paragastric lymph node,649.5,2.0
mandible,660.0,1.0
childhood acute myeloid leukemia with maturation,662.0,1.0
pyriform fossa squamous cell carcinoma,674.0,1.0
ovary,691.0,1.0
thyroid gland sarcoma,698.0,1.0
adult acute myeloid leukemia,717.0,22.0
childhood b acute lymphoblastic leukemia,725.0,9.0
tonsillar squamous cell carcinoma,733.0,1.0
floor of mouth squamous cell carcinoma,736.0,1.0
vulvar melanoma,756.0,1.0
childhood acute monocytic leukemia,761.0,2.0
hereditary spherocytosis,786.0,1.0
adult b acute lymphoblastic leukemia,822.0,3.0
gastric choriocarcinoma,843.0,1.0
follicular lymphoma,850.5,2.0
primary effusion lymphoma,861.0,3.0
squamous cell carcinoma,881.0,1.0
gestational choriocarcinoma,881.0,2.0
epithelioid sarcoma,887.0,1.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,895.0,1.0
diffuse large b-cell lymphoma activated b-cell type,899.0,1.0
splenic lymphoma with circulating villous lymphocytes,929.0,1.0
gastric fundus carcinoma,945.0,1.0
meninges,955.0,1.0
acute myelomonocytic leukemia,955.0,1.0
left cervical lymph node,957.0,1.0
thyroid gland papillary carcinoma,957.0,1.0
